What Role Monoclonal Antibodies Play in Protein A Resin Market Growth?

The major protein A resin market drivers are the increasing geriatric population, prevalence of chronic diseases, funding for protein research, and need to meet the need for therapies for various conditions. The market revenue is projected to surge to $1,020.7 million by 2030, from $486.4 million in 2019, at a 7.0% CAGR during the forecast period (2019-2030). Protein A resin is used as a separation medium during purification processes, such immunoprecipitation and chromatography. It separates biochemical mixtures based on the enzyme-substrate, antigen-antibody, and receptor-nucleic acid interactions.

Download sample copy of this report at@ https://www.psmarketresearch.com/market-analysis/protein-a-resin-market/report-sample

Based on source, the protein A resin market is bifurcated into natural and recombinant, of which the recombinant bifurcation would display the higher CAGR, of 7.5%, during the forecast period. This is because recombinant protein A resins are heavily used during the production of monoclonal antibodies (mAb). Earlier, pharmaceutical companies did not pursue mAbs, owing to their stability, size, degradation rate, and delivery limitations. But, with increasing funding and focus of private and public institutions on protein-based research, the development of mAbs is picking up pace.

The application segment of the market also has two bifurcations -- antibody purification and immunoprecipitation -- of which antibody purification held the larger share in 2019 and it would also grow faster during the forecast period, at a 7.2% CAGR. Similarly, of the two bifurcations within the end user segment -- academic institutes & research laboratories and biotechnology & pharmaceutical industries -- the latter dominated the protein A resin market in 2019, with a 91.6% value share. This end user consumes the biomaterial in huge amounts to produce mAbs.

One of the primary reasons behind the rising demand for monoclonal antibodies is the increasing incidence of chronic diseases. mAbs display a suitable pharmacokinetic profile, their solubility can be customized, and they also have a lesser chance of inducing an immune response, which is essential for the treatment to work. The diseases caused by hepatitis C virus (HCV), human immunodeficiency virus (HIV), and human papillomavirus (HPV) are increasing in prevalence, due to the low accessibility of healthcare in developing nations.

Geographically, North America led the market in 2019, with a share of 37.4%, owing to the increasing requirement for protein therapeutics for chronic diseases and rising number of biopharmaceuticals with the Food and Drug Administration's approval. During the forecast period, Asia-Pacific (APAC) would observe the fastest progress in the protein A resin market during the forecast period, at a 7.8% CAGR. This would be because of the rising usage of such biomaterial in drug research, technological advancements, growing pharmaceutical sector, and surging demand for vaccines and other therapeutics.

Browse full report at@ https://www.psmarketresearch.com/market-analysis/protein-a-resin-market

Protein A Resin Market Segmentation
Based on Source
o Recombinant
o Natural
Based on Matrix
o Agarose-Based
o Glass or Silica-Based
o Organic Polymer-Based
Based on Application
o Antibody Purification
o Immunoprecipitation
Based on End User
o Biotechnology and Pharmaceutical Industries
o Academic Institutes and Research Laboratories

Contact:
P&S Intelligence
International: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com
Blog: https://psintelligence.blogspot.com

About P&S Intelligence

P&S Intelligence is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.

This release was published on openPR.